Climate change is driving a rise in tick-borne diseases. Here’s what to know.Are you patients aware of these basics when it comes to dealing with ticks? Beta-blockers post-MI: Should we stop using them if patients have normal heart function?For patients who present with an MI and have an LVEF ≥ 50% post-vascularization, the benefit of beta-blockers, if one truly exists, is likely modest at best. GLP-1 receptor agonists and pancreatic cancer This study provides reassuring data that GLP-1 receptor agonists are not associated with an increased risk of pancreatic cancer. Global vaccination efforts stall, leaving millions of children vulnerable to preventable diseases Protection from measles in particular dropped in 100 countries between 2010 and 2019, unravelling decades of progress. Can fecal microbiota therapy be used as a first-line treatment for C. difficile? Study examines the use of fecal microbiota transplantation versus oral vancomycin for primary treatment of Clostridioides difficile infection. Credibility without competence? When a bubble sheet replaces the bimanual exam. Antidepressant-induced weight gain Antidepressants are commonly used medications, with about 16% of people in Canada using antidepressants in 2023. PPIs—An easy ‘hi’ but a difficult goodbye It is important to inform patients that they are quite likely to experience some rebound symptoms when reducing the dose or discontinuing their PPIs. Pharmacist ordered to take course after refusing to alcohol swab before administering flu shot According to the patient’s complaint, the pharmacist refused to clean his shoulder, stating that he did not want to touch him due to COVID-19 concerns, and handed the patient a swab for him to clean himself. How well is Ontario doing when it comes to pharmacist prescribing for dermatology problems? The service is popular, but missing the mark when it comes to underserviced populations. First Previous 4 5 6 7 8 Next Last
